Worldwide use of intrauterine contraception: a review.

Abstract:

BACKGROUND:Globally, 14.3% of women of reproductive age use intrauterine contraception (IUC), but the distribution of IUC users is strikingly nonuniform. In some countries, the percentage of women using IUC is <2%, whereas in other countries, it is >40%. Reasons for this large variation are not well documented. The aims of this review are to describe the worldwide variation in IUC utilization and to explore factors that impact utilization rates among women of reproductive age in different continents and countries. STUDY DESIGN:Published literature from 1982 to 2012 was reviewed, using Medline and Embase, to identify publications reporting diverse practices of IUC provision, including variation in the types of IUC available. Local experts who are active members of international advisory groups or congresses were also consulted to document variations in practice regulations, published guidelines and cost of IUC in different countries. RESULTS:Multiple factors appear to contribute to global variability in IUC use, including government policy on family planning, the types of health care providers (HCPs) who are authorized to place and remove IUC, the medicolegal environment, the availability of practical training for HCPs, cost differences and the geographical spread of clinics providing IUC services. CONCLUSIONS:Our review shows that the use of IUC is influenced more by factors such as geographic differences, government policy and the HCP's educational level than by medical eligibility criteria. These factors can be influenced through education of HCPs and greater understanding among policy makers of the effectiveness and cost-effectiveness of IUC methods. IMPLICATIONS:Globally, 14.3% of women of reproductive age use IUC, but the percentage of women using IUC is in some countries <2%, whereas in other countries, it is >40%. This paper reviews the reasons for this diverse and highlights possible starting points to improve the inclusion of IUC in contraceptive counseling.

journal_name

Contraception

journal_title

Contraception

authors

Buhling KJ,Zite NB,Lotke P,Black K,INTRA Writing Group.

doi

10.1016/j.contraception.2013.11.011

subject

Has Abstract

pub_date

2014-03-01 00:00:00

pages

162-73

issue

3

eissn

0010-7824

issn

1879-0518

pii

S0010-7824(13)00733-6

journal_volume

89

pub_type

杂志文章,评审
  • Safety evaluation of a male injectable antifertility agent, styrene maleic anhydride, in rats.

    abstract::Injection of a polymer, styrene maleic anhydride (SMA), into the lumen of the vas deferens of rats, was observed to have effective and reversible contraception. The safety evaluation of the polymer, for 90 days, was carried out in Charles Foster male rats. There have been no significant changes in any of the toxicity ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(89)80010-1

    authors: Sethi N,Srivastava RK,Singh RK

    更新日期:1989-02-01 00:00:00

  • Disparities in contraceptive knowledge, attitude and use between Hispanic and non-Hispanic whites.

    abstract:BACKGROUND:Higher rates of unwanted pregnancies and lower rates of contraceptive use have been reported among Hispanic women than among non-Hispanic whites. Despite these differences, it is unclear how these groups differ with respect to various psychosocial factors that are associated with contraceptive decision makin...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2006.02.010

    authors: Sangi-Haghpeykar H,Ali N,Posner S,Poindexter AN

    更新日期:2006-08-01 00:00:00

  • Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited.

    abstract:BACKGROUND:Determining medical abortion outcome commonly includes a costly evaluation such as ultrasonography or serial serum hCG testing. Urine pregnancy testing may represent a less costly alternative. METHODS:This prospective diagnostic test evaluation study was part of a multisite randomized trial of 1080 women un...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2007.01.021

    authors: Godfrey EM,Anderson A,Fielding SL,Meyn L,Creinin MD

    更新日期:2007-05-01 00:00:00

  • Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol.

    abstract::The pharmacokinetics and androgenic activity of Estrostep, a new oral contraceptive providing low-dose estrogen in a graduated sequence with a constant dose of progestin, were characterized in an open-label, nonrandomized study in 17 normally cycling women treated for three cycles with Estrostep. Women received 1 mg o...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0010-7824(01)00179-2

    authors: Boyd RA,Zegarac EA,Posvar EL,Flack MR

    更新日期:2001-02-01 00:00:00

  • Pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant women.

    abstract::RU 486 and three of its metabolites (RU 42633-monodemethyl, RU 42848-didemethyl, and RU 42698-hydroxymetabolite) were determined by HPLC in plasma from nine non-pregnant and 36 pregnant women. Each non-pregnant subject took an oral dose of RU 486 (25, 100, 400 and 600 mg consecutively) once per menstrual cycle. Six of...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(93)90004-q

    authors: Shi YE,Ye ZH,He CH,Zhang GQ,Xu JQ,Van Look PF,Fotherby K

    更新日期:1993-08-01 00:00:00

  • Efficacy of nonhormonal vaginal contraceptives from a hydrogel delivery system.

    abstract::This investigation describes the synthesis of a biodegradable hydrogel composed of a core surrounded by four concentric sheaths containing dextran, copolymers of polylactide and epsilon-caprolactone. The hydrogel was impregnated with iron (II) d-gluconate dihydrate, which causes complete spermiostasis due to lipid per...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2004.02.015

    authors: Saxena BB,Singh M,Gospin RM,Chu CC,Ledger WJ

    更新日期:2004-09-01 00:00:00

  • Comparative cross-over pharmacokinetic study on two types of postcoital contraceptive tablets containing levonorgestrel.

    abstract::A pharmaceutical and pharmacokinetic study was carried out on levonorgestrel tablets from two different sources (Hungarian- and Chinese-made). Both preparations contained 0.75 mg levonorgestrel and had been shown to have similar contraceptive efficacy and side effects when used for postcoital contraception. Absorption...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(90)90064-3

    authors: He CH,Shi YE,Liao DL,Zhu YH,Xu JQ,Matlin SA,Vince PM,Fotherby K,Van Look PF

    更新日期:1990-05-01 00:00:00

  • Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials.

    abstract::This report combines the data obtained in three multicenter efficacy studies with a new triphasic oral contraceptive combination containing desogestrel (DSG) and ethinyl estradiol (EE). The studies were conducted at 40 investigational sites in the United States (38 centers) and Canada (2 centers) in support of the FDA...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/0010-7824(93)90078-l

    authors: Darney P

    更新日期:1993-10-01 00:00:00

  • Bleeding patterns of women using extended regimens of the contraceptive vaginal ring.

    abstract:INTRODUCTION:This prospective observational study evaluated the bleeding patterns of women using a vaginal ring releasing 120 microg of etonogestrel and 15 microg of ethinyl estradiol daily, over a continuous period of 84 days followed by 7 ring-free days. METHODS:The study enrolled 75 volunteers aged 18 to 37 years. ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2006.10.009

    authors: Barreiros FA,Guazzelli CA,de Araújo FF,Barbosa R

    更新日期:2007-03-01 00:00:00

  • Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial.

    abstract:BACKGROUND:This study was conducted to compare breast epithelial-cell proliferation and estrogen and progesterone receptor levels in women taking one of two oral contraceptives (OCs) containing the same dose of estrogen but different doses of the progestin norethindrone (NET). STUDY DESIGN:Thirty-three women were rand...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2011.12.015

    authors: Hovanessian-Larsen L,Taylor D,Hawes D,Spicer DV,Press MF,Wu AH,Pike MC,Pearce CL

    更新日期:2012-09-01 00:00:00

  • Evaluation of shorter mifepristone to misoprostol intervals for second trimester medical abortion: a retrospective cohort study.

    abstract:OBJECTIVES:To assess shorter mifepristone-misoprostol intervals compared to current guidelines for second trimester medical abortion on total abortion time (mifepristone to fetal expulsion) and induction time (first misoprostol to fetal expulsion). METHODS:This retrospective cohort study included women who elected for...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.06.009

    authors: Henkel A,Lerma K,Blumenthal PD,Shaw KA

    更新日期:2020-11-01 00:00:00

  • Transdermal delivery of steroids.

    abstract::The advantages of delivering drugs through the skin for systemic therapy have been widely recognized and represent a growing sector in drug development. Transdermal delivery of steroids is also a rapidly expanding field and in various clinical situations where hormonal replacement therapy is needed this route of admin...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/0010-7824(89)90012-7

    authors: Sitruk-Ware R

    更新日期:1989-01-01 00:00:00

  • Acceptability of levonorgestrel subdermal implants versus tubal ligation for long-term contraception in a rural population of Zimbabwe.

    abstract::This prospective cohort study of 257 rural Zimbabwean women was designed to compare patient satisfaction with levonorgestrel subdermal implants (Norplant and reg;) versus tubal ligation (TL) as a method of long-term contraception. Women were equally satisfied with both methods. At 1 year, 96% of Norplant users and 97%...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2004.05.004

    authors: Mitchel MJ,Thistle P

    更新日期:2004-12-01 00:00:00

  • Effect of temperature and pH on contraceptive gel viscosity.

    abstract::The rheological properties of four commercially available spermicidal gels (two polyacrylic acid derivatives and two carboxymethylcellulose based) and their dilutions with a vaginal fluid simulant (pH 4.2) and a semen simulant (pH 7.7) were measured at 25 degrees C and 37 degrees C over a biologically relevant range o...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(02)00430-4

    authors: Owen DH,Peters JJ,Lavine ML,Katz DF

    更新日期:2003-01-01 00:00:00

  • Long-term effects of lonidamine on mouse testes.

    abstract::Lonidamine (LND) [1-(2,4-dichlorobenzyl)-1H-indazole-3-carboxylic acid] is a well-known antispermatogenic drug. The aim of this study was to identify its possible long-term sequelae on the reproductive system of mice as compared with rats, where most data have been obtained until now. Sexually mature CD1 male mice wer...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2005.05.019

    authors: Maranghi F,Mantovani A,Macrì C,Romeo A,Eleuteri P,Leter G,Rescia M,Spanò M,Saso L

    更新日期:2005-10-01 00:00:00

  • Use of cauda epididymis extract as immunocontraceptive.

    abstract::The objective of this study was to evaluate use of a cauda epididymis extract (CEE) as an immunocontraceptive in rats. Twenty-two rats in puberty or 19 rats that gave birth once (primipara) were immunized with intraperitoneal (IP) injection of CEE. Rats in puberty received one or two injections of CEE containing 1.5 x...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(02)00406-7

    authors: Risvanli A,Aydin M,Kaygusuzoglu E,Bulut H,Apaydin AM,Timurkan H

    更新日期:2002-12-01 00:00:00

  • Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.

    abstract::The clinical performance of the Copper T 380A (TCu 380A) and the Lippes Loop intrauterine devices (IUDs) were evaluated for 12 months in a group of 710 women who had one of the two IUDs inserted. Results are from a randomized clinical trial conducted at three collaborating research sites located in three developing co...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/0010-7824(95)00119-u

    authors: Farr G,Amatya R,Acosta M,Ekwempu C,Kisninci H

    更新日期:1995-07-01 00:00:00

  • The incidence of gonorrhea in an abortion population.

    abstract::The incidence of gonorrhea was investigated in an abortion population. A total of 1021 women participated in this study. Three asymptomatic cases of gonorrhea were detected. None of these women had had gonorrhea before or had a previous abortion. No relation was found between the incidence of gonorrhea and age. The ab...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(80)90028-1

    authors: Querido L,Haspels AA

    更新日期:1980-10-01 00:00:00

  • Effect of a new contraceptive ring releasing 20 micrograms levonorgestrel daily on blood lipid levels and glucose tolerance.

    abstract::Fifteen healthy subjects used a contraceptive device, namely an intravaginal ring releasing 20 micrograms levonorgestrel daily, for 12 weeks. High, low and very low density fractions of cholesterol, triglyceride and phospholipids were measured, together with oral glucose tolerance before and after 12 weeks of use. The...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(84)90078-7

    authors: Elder MG,Lawson JP,Lucas S,Hamawi A,Trayner I,Fotherby K

    更新日期:1984-07-01 00:00:00

  • Efficacy of medical abortion prior to 6 gestational weeks: a systematic review.

    abstract:OBJECTIVE:The objective was to describe the efficacy of medical abortion using mifepristone and misoprostol for gestations less than 6 weeks. STUDY DESIGN:We searched PubMed and Cochrane databases for articles in any language that examined the success of mifepristone and misoprostol abortion at gestational ages <42 da...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2017.09.006

    authors: Kapp N,Baldwin MK,Rodriguez MI

    更新日期:2018-02-01 00:00:00

  • Two-year treatment with oral contraceptives in hyperprolactinemic patients.

    abstract::The aim of this prospective study was the follow-up for 2 years in symptoms, serum prolactin (PRL) levels, and radiological aspects of a group of young patients using oral contraceptives (OC) with hyperprolactinemia. A total of 16 hyperprolactinemic women (eight with idiopathic hyperprolactinemia and eight with pituit...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0010-7824(98)00069-9

    authors: Testa G,Vegetti W,Motta T,Alagna F,Bianchedi D,Carlucci C,Bianchi M,Parazzini F,Crosignani PG

    更新日期:1998-08-01 00:00:00

  • Fertility after discontinuation of contraception: a comprehensive review of the literature.

    abstract:BACKGROUND:Fear of adverse effects on subsequent fertility following reversible contraceptive use is an important concern for some women. STUDY DESIGN:We undertook a comprehensive and objective review of the literature for prospective studies reporting pregnancy rates in women following contraceptive cessation. One-ye...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2011.04.002

    authors: Mansour D,Gemzell-Danielsson K,Inki P,Jensen JT

    更新日期:2011-11-01 00:00:00

  • Utility and drawbacks of continuous use of a copper T IUD for 20 years.

    abstract::This article examines interrelated questions concerning the extent of need for contraception in women 40 years and older and the degree to which that need can be served when use of collared T IUDs is initiated in women aged 25-35 years. Differentials in the impacts of intrauterine device (IUD) use on health issues in ...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2007.01.016

    authors: Sivin I

    更新日期:2007-06-01 00:00:00

  • Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.

    abstract:BACKGROUND:Concomitant use of antiretroviral (ARV) and hormonal contraceptives may change the metabolism of each and the resulting safety profiles. We evaluated the safety and tolerability of depot medroxyprogesterone acetate (DMPA) among women on ARV. STUDY DESIGN:HIV-infected women on selected ARV regimens or no ARV...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2007.10.002

    authors: Watts DH,Park JG,Cohn SE,Yu S,Hitti J,Stek A,Clax PA,Muderspach L,Lertora JJ

    更新日期:2008-02-01 00:00:00

  • The protective influence of progestogen only contraception against vaginal moniliasis.

    abstract::The incidence of Candida albicans (C.A.) infection of the vagina was evaluated in vaginal discharges obtained from 85 subjects using a large battery of culture media and confirmatory tests. Twenty women using DMPA 150 mg i.m. contraceptive injections for more than one year (long-term users) were compared with forty 2n...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(79)90082-9

    authors: Toppozada M,Onsy FA,Fares E,Amir S,Shaala S

    更新日期:1979-08-01 00:00:00

  • Inhibition of progesterone-induced development of giant mitochondria in uterine glandular epithelial cells by an antiestrogen in rat.

    abstract::Effect of antiestrogen ormeloxifene on progesterone-induced development of giant mitochondria in uterine glandular epithelial cells in ovariectomized adult Sprague-Dawley rats was investigated. Antiestrogen tamoxifen and antiprogestin onapristone were used for comparison. Well-formed giant mitochondria were observed i...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(96)00197-7

    authors: Chauhan SC,Singh MM,Maitra SC,Kamboj VP

    更新日期:1996-10-01 00:00:00

  • Latin american experience with two low-dose oral contraceptives containing 30 microg ethinylestradiol/75 microg gestodene and 20 microg ethinylestradiol/150 microg desogestrel.

    abstract::The objective of this study was to compare cycle control, efficacy and tolerance of an oral contraceptive containing 20 microg ethinylestradiol and 150 microg desogestrel with a preparation containing 30 microg ethinylestradiol combined with 75 microg gestodene. This study involved 342 women and 4104 cycles use in Arg...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/s0010-7824(00)00153-0

    authors: Bassol S,Alvarado A,Celis C,Cravioto MC,Peralta O,Montaño R,Novelli J,Albornoz H,Kesseru E,Soares A,Petracco A,Isaia B,Mendes J,Bahamondes L,de Melo NR,Reyes-Marquez R,Albrecht G

    更新日期:2000-09-01 00:00:00

  • A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.

    abstract:BACKGROUND:Mirena is a levonorgestrel-releasing intrauterine system (LNG-IUS) that provides highly effective and long-acting progestogen-only contraception. OBJECTIVE:The objective of this study was to analyze the possible effects of using LNG-20 microg IUS on breast-feeding performance, infant growth and infant devel...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2005.04.004

    authors: Shaamash AH,Sayed GH,Hussien MM,Shaaban MM

    更新日期:2005-11-01 00:00:00

  • Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial.

    abstract:BACKGROUND:Barriers to intrauterine device (IUD) use in nulliparous women include fear of pain with insertion and provider perception of difficulty with insertion. The goal of this study was to evaluate whether misoprostol prior to IUD insertion in nulliparous women eased insertion and decreased pain. STUDY DESIGN:Thi...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2013.07.011

    authors: Lathrop E,Haddad L,McWhorter CP,Goedken P

    更新日期:2013-12-01 00:00:00

  • Controversies in family planning: persistently elevated serum human chorionic gonadotropin levels after aspiration abortion.

    abstract::Low but rising serum human chorionic gonadotropin (hCG) levels occur infrequently after an induced abortion. Because this scenario rarely occurs after suction aspiration, clinicians may have higher suspicion for an uncommon diagnosis. The differential diagnosis includes both common and uncommon diagnoses, such as inco...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2018.07.136

    authors: Chen MJ,Pymar H,Creinin MD

    更新日期:2018-12-01 00:00:00